BD (Becton, Dickinson and Company)

, /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Arthur (Art) Hu has been named executive vice president and chief information and digital officer, effective September 30. Hu brings more than 25 years of experience leading global technology, digital and business transformation initiatives at scale.

The portfolio you trust just got stronger Footprint Medical, now part of BD, brings innovative neonatal technologies to the BD family.

First-of-its-kind U.S. deployment of BD Vmax 160 expands pharmacy automation beyond traditional dispensing, helping health systems manage growing demand for specialty therapies, refrigerated medications, and increasingly complex fulfilment needs , /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Fairview Health Services has become the first health system in the United States to deploy the BD Vmax 160, a next...

Helping patients and caregivers understand their options, ask the right questions, and take the next step with confidence can make a huge difference. By Mike Cusack, Worldwide President, BD Urology & Critical Care Throughout my career as a healthcare executive, I’ve seen how overwhelming it can be for patients and caregivers to navigate the healthcare system.

Enniscorthy, Co. Wexford, Ireland (September 10, 2026) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, is celebrating 30 years of innovation and shared prosperity at its manufacturing facility in Enniscorthy, Co. Wexford. The milestone marks three decades of manufacturing excellence, community partnership and investment in the region's future.

As both a NICU mom and nurse, I've seen firsthand why healthcare’s smallest and most vulnerable patients need solutions built just for them By Nancy Wilson, MBA, BSN, RN, VA-BC, Senior Manager, Medical Affairs, BD – Medication Delivery Solutions The NICU was personal, then it became my purpose More than 30 years ago, my naturally occurring triplets were born 11 weeks early, and suddenly, the NICU became part of our lives.

STANCE trial surpasses a key enrollment milestone, advancing the clinical evaluation of GalaFLEX LITE™ Scaffold and generating evidence to support its use in breast revision surgery for capsular contracture , /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a significant milestone in its advanced tissue regeneration strategy and expansion efforts with the STANCE clinical trial evaluating GalaFLEX LITE™ Scaffold in...

, /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 9:30 a.m. Eastern Time. The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.

, /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Gary Sorsher has been named executive vice president and chief quality officer, effective September 8. Sorsher brings more than 30 years of experience leading quality organizations across world-class MedTech companies.

Enrollment completed in the first large-scale randomized study evaluating Phasix™ Mesh for incisional hernia prevention, a significant unmet need following abdominal surgery , /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a significant milestone in its advanced tissue regeneration strategy and expansion efforts with successful completion of enrollment in the PREVENT clinical trial evaluating Phasix™ Mesh for the...